May « 2014 « Science and Enterprise

Partnership to Test Genome-Driven Breast Cancer Therapies

By Alan, on May 15th, 2014%

(National Cancer Institute)

15 May 2014. Researchers at Indiana University’s medical school in Indianapolis and Paradigm, a genomic sequencing company in Ann Arbor, Michigan are enrolling patients in a clinical study testing the ability of genomic sequencing to find optimal treatments for an aggressive type of breast cancer. The study covers women with . . . → Read More: Partnership to Test Genome-Driven Breast Cancer Therapies

Trial Shows Polymer Dressing Reduces Surgical Scarring

By Alan, on May 15th, 2014%

(National Institutes of Health)

15 May 2014. A follow-up study of patients one year after cosmetic surgery shows a polymer adhesive dressing applied after the surgery reduced the formation of scars compared to untreated areas of the incision. The researchers tested the bandage made by Neodyne Biosciences of Menlo Park, California, and reported . . . → Read More: Trial Shows Polymer Dressing Reduces Surgical Scarring

Biopharm Starts Genetic Heart Disease Clinical Database

By Alan, on May 14th, 2014%

(NASA.gov)

14 May 2014. MyoKardia Inc., a biopharmaceutical company in South San Francisco, California, began a repository of clinical data on patients with genetic heart disorders. The database, known as Sarcomeric Human Cardiomyopathy Registry, or SHaRe, is a joint project with seven medical centers specializing in these conditions in the U.S., U.K., Netherlands, . . . → Read More: Biopharm Starts Genetic Heart Disease Clinical Database

Bayer, Boehringer Ingelheim Open Clinical Trial Data

By Alan, on May 14th, 2014%

(Photos8.com)

14 May 2014. Two more pharmaceutical companies, Bayer HealthCare and Boehringer Ingelheim, are making detailed data from clinical trials available to the larger scientific community. The two companies join several other pharmaceutical companies taking similar actions over the past several months.

Bayer HealthCare in Leverkusen, Germany is making its trial data available . . . → Read More: Bayer, Boehringer Ingelheim Open Clinical Trial Data

Electronic Circuits Developed That Become Flexible in Body

By Alan, on May 13th, 2014%

Jonathan Reeder (Univ of Texas – Dallas)

13 May 2014. Engineers and material scientists from University of Texas in Dallas and University of Tokyo in Japan developed electronic circuits encased in polymers that become flexible and adapt their shape to three-dimensional objects when implanted in mammals. The team from the labs of Walter . . . → Read More: Electronic Circuits Developed That Become Flexible in Body

Antioxidant-Rich Diets Fail to Reduce Heart Disease, Cancer

By Alan, on May 13th, 2014%

(Alex Brown/Flickr)

13 May 2014. In a study of Italians age 65 and older, researchers at Johns Hopkins University in Baltimore find people with diets high in the antioxidant resveratrol — found in berries, dark chocolate, and red wine — develop cardiac problems and cancer, and live no longer than people who consume smaller . . . → Read More: Antioxidant-Rich Diets Fail to Reduce Heart Disease, Cancer

Neurodegenerative Therapies Start-Up Gains $4.8M Seed Funds

By Alan, on May 12th, 2014%

3-D brain wiring illustration (NIH)

12 May 2014. Lysosomal Therapeutics Inc., a start-up developer of therapies for neurodegenerative disorders in Cambridge, Massachusetts, raised $4.8 million in seed financing, the enterprise’s initial operating funds. The company was begun by and is based on the research of Dimitri Krainc, a neurologist at Harvard Medical School . . . → Read More: Neurodegenerative Therapies Start-Up Gains $4.8M Seed Funds

Heart Disease in Lab Recreated with Stem Cells, Chip Device

By Alan, on May 12th, 2014%

Kevin Kit Parker (Harvard University)

12 May 2014. Medical and engineering researchers from Harvard University and affiliated hospitals created heart tissue with a genetic disorder on a chip-like device in the lab using stem cells. The results point to a new method for personalized lab testing of therapies for cardiac patients with cells . . . → Read More: Heart Disease in Lab Recreated with Stem Cells, Chip Device

1.1M Health Center Patients Left Uninsured in Opt-Out States

By Alan, on May 9th, 2014%

(HRSA.gov)

9 May 2014. A new report estimates some 1.1 million clients of community health centers will be left without health insurance in U.S. states that choose not to expand Medicaid, as permitted under the Affordable Care Act. The report was prepared by the School of Public Health at George Washington University in . . . → Read More: 1.1M Health Center Patients Left Uninsured in Opt-Out States

Remote Device Monitoring Linked to Higher Survival Rates

By Alan, on May 9th, 2014%

(Photos8.com)

9 May 2014. A study of more than 260,000 patients with implanted heart devices shows those who took part in frequent remote monitoring by device maker St. Jude Medical, also had more than twice the survival rate of patients without remote monitoring. The findings from the study, which show a correlation and . . . → Read More: Remote Device Monitoring Linked to Higher Survival Rates

Subscribe for email alerts

Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Like us on Facebook

Specials

Guest Posts

Please share Science & Enterprise